Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig G Hartford

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|January 22, 2021
Artificial Intelligence in Pharmacovigilance: Scoping Points to ConsiderManfred Hauben, Craig G Hartford
Drug Safety|July 29, 2006
Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelinesCraig G Hartford, Kasia S Petchel, Hani Mickail, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|January 22, 2021
Artificial Intelligence in Pharmacovigilance: Scoping Points to ConsiderManfred Hauben, Craig G Hartford
Drug Safety|July 29, 2006
Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelinesCraig G Hartford, Kasia S Petchel, Hani Mickail, et al.
Pageof 1